Quality of life and drug costs associated with switching antipsychotic medication to once-daily extended release quetiapine fumarate in patients with schizophrenia

Krister Järbrink; Noemi Kreif; Agnes Benedict; Julie Locklear

Quality of life and drug costs associated with switching antipsychotic medication to once-daily extended release quetiapine fumarate in patients with schizophrenia

Krister Järbrink, Noemi Kreif, Agnes Benedict, Julie Locklear

Centre for Health Economics

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	709-716
Number of pages	8
Journal	Current Medical Research and Opinion
Volume	25
Issue number	3
Publication status	Published - 2009

Cite this

@article{2e2bede3456746e1a1b285d1d71c62fc,

title = "Quality of life and drug costs associated with switching antipsychotic medication to once-daily extended release quetiapine fumarate in patients with schizophrenia",

author = "Krister J{\"a}rbrink and Noemi Kreif and Agnes Benedict and Julie Locklear",

year = "2009",

language = "English",

volume = "25",

pages = "709--716",

journal = "Current Medical Research and Opinion",

publisher = "Informa Healthcare",

number = "3",

}

TY - JOUR

T1 - Quality of life and drug costs associated with switching antipsychotic medication to once-daily extended release quetiapine fumarate in patients with schizophrenia

AU - Järbrink, Krister

AU - Kreif, Noemi

AU - Benedict, Agnes

AU - Locklear, Julie

PY - 2009

Y1 - 2009

M3 - Article

VL - 25

SP - 709

EP - 716

JO - Current Medical Research and Opinion

JF - Current Medical Research and Opinion

IS - 3

ER -